Literature DB >> 20142594

Facilitating informed decisions regarding microsatellite instability testing among high-risk individuals diagnosed with colorectal cancer.

Sharon L Manne1, Neal J Meropol, David S Weinberg, Hetal Vig, Zohra Ali-Khan Catts, Cheri Manning, Eric Ross, Kristen Shannon, Daniel C Chung.   

Abstract

PURPOSE: To evaluate the impact of a CD-ROM intervention in the education of patients with suspected Lynch syndrome (LS) about microsatellite instability (MSI) and immunohisochemistry (IHC) testing. PATIENTS AND METHODS: Two hundred thirteen patients meeting Bethesda criteria were randomly assigned to receive either a brief educational session with a health educator (n = 105) or a brief educational session plus a CD-ROM (n = 108). Assessments were administered at baseline and 2 weeks post-treatment. Primary outcomes included MSI and IHC knowledge and level of satisfaction with and completeness of the preparation to make the decision for MSI testing. Secondary outcomes included decisional conflict, difficulty making the decision, cancer-specific and global anxiety, and level of discussion about MSI testing with family and friends.
RESULTS: Participants in the education plus CD-ROM condition reported significant increases in knowledge about the MSI and IHC tests, greater satisfaction with the preparation to make a decision for testing, lower decisional conflict, and greater decisional self-efficacy. The effects of the education plus CD-ROM on most outcomes were not moderated by preintervention levels of exposure to MSI testing, family support for MSI testing, or the family history of cancer.
CONCLUSION: Incorporation of new media education strategies for individuals at risk for LS may be a valuable component of the informed consent process. As clinical criteria for MSI and IHC testing continue to expand, the need for alternative educational approaches to meet this increased demand could be met by the self-administered computer-based strategy that we described.

Entities:  

Mesh:

Year:  2010        PMID: 20142594      PMCID: PMC2834496          DOI: 10.1200/JCO.2009.25.0399

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  25 in total

Review 1.  Decision aids for patients considering options affecting cancer outcomes: evidence of efficacy and policy implications.

Authors:  A M O'Connor; V Fiset; C DeGrasse; I D Graham; W Evans; D Stacey; A Laupacis; P Tugwell
Journal:  J Natl Cancer Inst Monogr       Date:  1999

2.  The colon cancer burden of genetically defined hereditary nonpolyposis colon cancer.

Authors:  W S Samowitz; K Curtin; H H Lin; M A Robertson; D Schaffer; M Nichols; K Gruenthal; M F Leppert; M L Slattery
Journal:  Gastroenterology       Date:  2001-10       Impact factor: 22.682

Review 3.  Hereditary colorectal cancer.

Authors:  Henry T Lynch; Albert de la Chapelle
Journal:  N Engl J Med       Date:  2003-03-06       Impact factor: 91.245

4.  Cancer patients' information needs and information seeking behaviour: in depth interview study.

Authors:  G M Leydon; M Boulton; C Moynihan; A Jones; J Mossman; M Boudioni; K McPherson
Journal:  BMJ       Date:  2000-04-01

5.  A new, brief questionnaire (PEQ) developed in primary health care for measuring patients' experience of interaction, emotion and consultation outcome.

Authors:  S Steine; A Finset; E Laerum
Journal:  Fam Pract       Date:  2001-08       Impact factor: 2.267

Review 6.  Decision aids for people facing health treatment or screening decisions.

Authors:  A M O'Connor; D Stacey; D Rovner; M Holmes-Rovner; J Tetroe; H Llewellyn-Thomas; V Entwistle; A Rostom; V Fiset; M Barry; J Jones
Journal:  Cochrane Database Syst Rev       Date:  2001

7.  Impact of educational print materials on knowledge, attitudes, and interest in BRCA1/BRCA2: testing among Ashkenazi Jewish women.

Authors:  M D Schwartz; J Benkendorf; C Lerman; C Isaacs; A Ryan-Robertson; L Johnson
Journal:  Cancer       Date:  2001-08-15       Impact factor: 6.860

8.  An interactive computer program can effectively educate patients about genetic testing for breast cancer susceptibility.

Authors:  M J Green; B B Biesecker; A M McInerney; D Mauger; N Fost
Journal:  Am J Med Genet       Date:  2001-09-15

Review 9.  The hereditary nonpolyposis colorectal cancer syndrome: genetics and clinical implications.

Authors:  Daniel C Chung; Anil K Rustgi
Journal:  Ann Intern Med       Date:  2003-04-01       Impact factor: 25.391

Review 10.  EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome.

Authors:  Glenn E Palomaki; Monica R McClain; Stephanie Melillo; Heather L Hampel; Stephen N Thibodeau
Journal:  Genet Med       Date:  2009-01       Impact factor: 8.822

View more
  18 in total

1.  Universal tumor screening for Lynch syndrome: perspectives of Canadian pathologists and genetic counselors.

Authors:  Elizabeth Dicks; Daryl Pullman; Ken Kao; Andrée MacMillan; Charlene Simmonds; Holly Etchegary
Journal:  J Community Genet       Date:  2018-11-21

2.  The evolution of personalized cancer genetic counseling in the era of personalized medicine.

Authors:  Hetal S Vig; Catharine Wang
Journal:  Fam Cancer       Date:  2012-09       Impact factor: 2.375

3.  Effects of a decision support intervention on decisional conflict associated with microsatellite instability testing.

Authors:  Michael J Hall; Sharon L Manne; Gary Winkel; Daniel S Chung; David S Weinberg; Neal J Meropol
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-01-06       Impact factor: 4.254

4.  Evaluating the utilization of educational materials in communicating about Lynch syndrome to at-risk relatives.

Authors:  Kristen Dilzell; Kerry Kingham; Kelly Ormond; Uri Ladabaum
Journal:  Fam Cancer       Date:  2014-09       Impact factor: 2.375

5.  Application of best practice approaches for designing decision support tools: the preparatory education about clinical trials (PRE-ACT) study.

Authors:  Linda Fleisher; Dominique G Ruggieri; Suzanne M Miller; Sharon Manne; Terrance Albrecht; Joanne Buzaglo; Michael A Collins; Michael Katz; Tyler G Kinzy; Tasnuva Liu; Cheri Manning; Ellen Specker Charap; Jennifer Millard; Dawn M Miller; David Poole; Stephanie Raivitch; Nancy Roach; Eric A Ross; Neal J Meropol
Journal:  Patient Educ Couns       Date:  2014-04-21

Review 6.  100 years Lynch syndrome: what have we learned about psychosocial issues?

Authors:  Eveline M A Bleiker; Mary Jane Esplen; Bettina Meiser; Helle Vendel Petersen; Andrea Farkas Patenaude
Journal:  Fam Cancer       Date:  2013-06       Impact factor: 2.375

7.  The relationships among knowledge, self-efficacy, preparedness, decisional conflict, and decisions to participate in a cancer clinical trial.

Authors:  S M Miller; S V Hudson; B L Egleston; S Manne; J S Buzaglo; K Devarajan; L Fleisher; J Millard; N Solarino; J Trinastic; N J Meropol
Journal:  Psychooncology       Date:  2012-02-14       Impact factor: 3.894

8.  Health behaviors in patients and families with hereditary colorectal cancer.

Authors:  Allison M Burton; Shelly R Hovick; Susan K Peterson
Journal:  Clin Colon Rectal Surg       Date:  2012-06

9.  Financial Concerns About Participation in Clinical Trials Among Patients With Cancer.

Authors:  Yu-Ning Wong; Mark D Schluchter; Terrance L Albrecht; Al Bowen Benson; Joanne Buzaglo; Michael Collins; Anne Lederman Flamm; Linda Fleisher; Michael Katz; Tyler G Kinzy; Tasnuva M Liu; Sharon Manne; Seunghee Margevicius; Dawn M Miller; Suzanne M Miller; David Poole; Stephanie Raivitch; Nancy Roach; Eric Ross; Neal J Meropol
Journal:  J Clin Oncol       Date:  2015-12-23       Impact factor: 44.544

10.  Knowledge, attitudes, and self-efficacy as predictors of preparedness for oncology clinical trials: a mediational model.

Authors:  Sharon Manne; Deborah Kashy; Terrance Albrecht; Yu-Ning Wong; Anne Lederman Flamm; Al B Benson; Suzanne M Miller; Linda Fleisher; Joanne Buzaglo; Nancy Roach; Michael Katz; Eric Ross; Michael Collins; David Poole; Stephanie Raivitch; Dawn M Miller; Tyler G Kinzy; Tasnuva Liu; Neal J Meropol
Journal:  Med Decis Making       Date:  2013-11-18       Impact factor: 2.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.